| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2016 | AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. | Li, CW ; Xia, W; Lim, SO; Hsu, JL; Huo, L; Wu, Y; Li, LY; Lai, CC; Chang, SS; Hsu, YH; Sun, HL; Kim, J; Yamaguchi, H; Lee, DF; Wang, H; Wang, Y; Chou, CK; Hsu, JM; Lai, YJ; LaBaff, AM; Ding, Q; Ko, HW; Tsai, FJ; Tsai, CH; Hortobagyi, GN; Hung, MC | Cancer research 76(6), 1451-1462 | | | |
| 2018 | Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer. | Shao, B; Li, CW; Lim, SO; Sun, L; Lai, YJ; Hou, J; Liu, C; Chang, CW; Qiu, Y; Hsu, JM; Chan, LC; Zha, Z; Li, H; Hung, MC | American journal of cancer research 8(9), 1837-1846 | | | |
| 2016 | Deubiquitination and Stabilization of PD-L1 by CSN5. | Lim, SO; Li, CW ; Xia, W; Cha, JH; Chan, LC; Wu, Y; Chang, SS; Lin, WC; Hsu, JM; Hsu, YH; Kim, T; Chang, WC; Hsu, JL; Yamaguchi, H; Ding, Q; Wang, Y; Yang, Y; Chen, CH; Sahin, AA; Yu, D; Hortobagyi, GN; Hung, MC | Cancer cell 30(6), 925-939 | | | |
| 2018 | Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. | Li, CW; Lim, SO; Chung, EM; Kim, YS; Park, AH; Yao, J; Cha, JH; Xia, W; Chan, LC; Kim, T; Chang, SS; Lee, HH; Chou, CK; Liu, YL; Yeh, HC; Perillo, EP; Dunn, AK; Kuo, CW; Khoo, KH ; Hsu, JL; Wu, Y; Hsu, JM; Yamaguchi, H; Huang, TH; Sahin, AA; Hortobagyi, GN; Yoo, SS; Hung, MC | Cancer cell 33(2), 187-201.e10 | | | |
| 2018 | Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. | Yang, Y; Li, CW; Chan, LC; Wei, Y; Hsu, JM; Xia, W; Cha, JH; Hou, J; Hsu, JL; Sun, L; Hung, MC | Cell research 28(8), 862-864 | | | |
| 2011 | FOXO3a dependent mechanism of E1A-Induced chemosensitization. | Su, JL; Cheng, X; Yamaguchi, H; Chang, YW; Hou, CF; Lee, DF; Ko, HW; Hua, KT; Wang, YN; Hsiao, M; Chen, PB; Hsu, JM; Bast, RC; Hortobagyi, GN; Hung, MC | Cancer Res Nov. 1;71(21):6878-6887. Cite 1 | | | |
| 2016 | Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. | Li, CW ; Lim, SO; Xia, W; Lee, HH; Chan, LC; Kuo, CW; Khoo, KH ; Chang, SS; Cha, JH; Kim, T; Hsu, JL; Wu, Y; Hsu, JM; Yamaguchi, H; Ding, Q; Wang, Y; Yao, J; Lee, CC; Wu, HJ; Sahin, AA; Allison, JP; Yu, D; Hortobagyi, GN; Hung, MC | Nature communications 7, 12632 | | | |
| 2018 | Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing. | Sun, LL; Yang, RY; Li, CW; Chen, MK; Shao, B; Hsu, JM; Chan, LC; Yang, Y; Hsu, JL; Lai, YJ; Hung, MC | American journal of cancer research 8(7), 1307-1316 | | | |
| 2019 | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | Li, H; Li, CW ; Li, X; Ding, Q; Guo, L; Liu, S; Liu, C; Lai, CC; Hsu, JM; Dong, Q; Xia, W; Hsu, JL; Yamaguchi, H; Du, Y; Lai, YJ; Sun, X; Koller, PB; Ye, Q; Hung, MC | Gastroenterology 156(6), 1849-1861.e13 | | | |
| 2019 | Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer. | Han, Y; Li, CW ; Hsu, JM; Hsu, JL; Chan, LC; Tan, X; He, GJ | American journal of cancer research 9(4), 800-815 | | | |
| 2016 | Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. | Wang, Y; Hsu, JM; Kang, Y; Wei, Y; Lee, PC; Chang, SJ; Hsu, YH; Hsu, JL; Wang, HL; Chang, WC; Li, CW ; Liao, HW; Chang, SS; Xia, W; Ko, HW; Chou, CK; Fleming, JB; Wang, H; Hwang, RF; Chen, Y; Qin, J; Hung, MC | Cancer research 76(23), 7049-7058 | | | |
| 2019 | Palmitoylation stabilizes PD-L1 to promote breast tumor growth. | Yang, Y; Hsu, JM; Sun, L; Chan, LC; Li, CW ; Hsu, JL; Wei, Y; Xia, W; Hou, J; Qiu, Y; Hung, MC | Cell research 29(1), 83-86 | | | |
| 2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |
| 2018 | Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy. | Hsu, JM; Li, CW; Lai, YJ; Hung, MC | Cancer research 78(22), 6349-6353 | | | |
| 2018 | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | Hsu, JM; Xia, W; Hsu, YH; Chan, LC; Yu, WH; Cha, JH; Chen, CT; Liao, HW; Kuo, CW; Khoo, KH ; Hsu, JL; Li, CW; Lim, SO; Chang, SS; Chen, YC; Ren, GX; Hung, MC | Nature communications 9(1), 1908 | | | |
